Latest news
Is Standard BioTools Inc (LAB) Overvalued After Q2 Loss? EPS: -$0.21, Revenue: $20.1M -- GF Score: 33/100 - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:29:07 GMTStandard BioTools (LAB) Stock Rebound Leaves Revenue Slide And Losses In Focus - SahmSahm · Fri, 07 Aug 2026 07:00:00 GMTBlackRock, Inc. Reduces Standard BioTools Inc (LAB) Stake -- Sha - GuruFocusGuruFocus · Thu, 06 Aug 2026 01:33:07 GMTStandard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 22:50:26 GMTStandard BioTools Q2 revenue falls on consumables weakness - TradingViewTradingView · Wed, 05 Aug 2026 20:36:20 GMTSTANDARD BIOTOOLS ($LAB) Releases Q2 2026 Earnings - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 20:32:00 GMTSTANDARD BIOTOOLS INC. Q2 2026: Revenue $20.1M, EPS $(0.07) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTStandard BioTools: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:25:01 GMT